Recent Progress of Nanotechnology in Cancer Diagnostics and Therapeutics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 175
Special Issue Editors
Interests: nanoformulations; molecular imaging; nanoprobes; theranostic strategy; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is one of the leading diseases in the world that causes many human deaths. Despite the continuous improvements in cancer diagnostics and therapeutics, residual microtumors remain a significant problem. Contrast agents are playing a cruial role in clinical diagnostics of cancer, where they are employed to further enhance the tumor contrast for successful diagnostics. To this end, nanoparticle (NP)-based contrast agents continue to receive considerable attention where they offer an enhanced contrast with greater biocompatibilites compared to conventional contrast agents. In addition to the contrast properties, NPs are also being explored for possible applications in cancer therapy. NPs can be designed to selectively accumulate in cancer cells, thus providing “targeted” treatments that conventional techniques may not be able to deliver. As a result, NPs are being increasingly used in cancer treatments to improve patient outcomes and reduce side effects, particularly in chemotherapy, radiation therapy and phototherapy.
Considering these advantages of NPs, this Special Issue will mainly focus on the recent advances in nanomaterial-mediated therapeutics (including drug delivery, photothermal therapy, photodynamic therapy, radio therapy, etc.) and diagnostics (magnetic resonance, fluorescence, focused ultrasound, computed-tomography-based imaging modalities) approaches for conquering/detecting cancer tumors efficiently. We are greatly looking forward to receiving the submission of high-quality research papers, reviews and perspectives to this Special Issue.
Prof. Dr. Chia-Hao Su
Dr. Suresh Thangudu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- nanobiomaterials
- bioimaging
- contrast agents
- phototherapy
- drug delivery
- radio therapy
- theranostics
- molecular imaging
- nanomedicine
